Soligenix
$2.759876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-1.43%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell Soligenix and other stocks, options, ETFs, and crypto commission-free!
About SNGX
Soligenix, Inc. engages in the development and commercialization of products to treat rare disease. It operates through the following segments: BioTherapeutics and Vaccines/BioDefense. Read More The BioTherapeutics segment offers photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Vaccines/BioDefense segment includes active development programs for RiVax, ricin toxin vaccine candidate, OrbeShield, GI acute radiation syndrome therapeutic candidate, and SGX943, melioidosis therapeutic candidate. The company was founded in 1987 and is headquartered Princeton, NJ.
Employees
14
Headquarters
Princeton, New Jersey
Founded
1987
Market Cap
57.62M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
350.89K
High Today
$2.82
Low Today
$2.73
Open Price
$2.75
Volume
256.75K
52 Week High
$3.23
52 Week Low
$0.65
Collections
SNGX Earnings
-$0.18
-$0.12
-$0.06
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 24, Pre-Market
People Also Bought
AVEO Pharmaceuticals
12,447
$0.58
+3.78%Geron
31,598
$1.31
+1.55%Camber Energy
10,937
$1.54
-5.52%Verastem
17,386
$2.03
+1.50%Oragenics
47,652
$0.5449
+3.51%Biocept
20,145
$0.3367
+3.89%Taronis Technologies
9,797
$0.6599
-11.41%22nd Century Group
50,022
$1.02
-8.93%Titan Pharmaceuticals
19,324
$0.235
-6.04%Ocugen, Inc
10,863
$0.5475
-3.15%Pareteum
29,184
$0.7799
+1.58%FuelCell Energy
51,948